➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Medtronic
Harvard Business School
Dow
Mallinckrodt

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2013)

Docket   Start Trial Date Filed 2013-10-21
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties AMNEAL PHARMACEUTICALS LLC
Patents 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,093,298; 8,097,655; 8,415,395; 8,415,396; 8,440,721; 8,440,722
Attorneys Amy L. Greywitt
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Takeda Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-10-21 1 using COLCRYS®. A. United Sates Patent Number 7,906,519 (“the ‘519 Patent”), entitled “METHODS FOR CONCOl…prior to the expiration of United States Patent Nos. 7,906,519, 7,935,731, 8,093,298, 7,964,648, and 8,…648 and ‘297 Patents are collectively referred to herein as the “Patents.” 13. The Patents are listed in…. This is an action for patent infringement under the Food and Drug and Patent LaWs of the United States…States patents, including the right to sue and to recover for infringement thereof, Which patents contain External link to document
2014-05-13 32 , U.S. Patent No. 7,601,758 (the “’758 patent”), U.S. Patent No. 7,820,681 (the “’681 patent”), U.S. … of patent exclusivity on Colcrys®. These patents are U.S. Patent No. 7,619,004 (the “’004 patent”), …. Patent No.7,915,269 (the “’269 patent”), U.S. Patent No. 7,964,647 (the “’647 patent”); U.S. Patent…7,964,648 (the “’648 patent”), U.S. Patent No.7,981,938 (the “’938 patent”), U.S. Patent No.8,093,296 (the…the “’296 patent”), U.S. Patent No.8,093,297 (the “’297 patent”), U.S. Patent No. 8,097,655 (the “’655 External link to document
2014-05-13 33 Exhibit D “Patents-in-suit” means U.S. Patent No. 7,906,519, U.S. Patent No. 7,935,731, U.S. Patent No. 7,…7,964,648, U.S. Patent No. 8,093,297, and U.S. Patent No. 8,093,298. G. “Identify” means…decision. INTERROGATORY NO. 2: For each Patent-in-suit that Amneal contends is invalid, describe…contention including: (1) the identification of each patent; (2) the identification of each claim; (3) the… NO. 3: For each asserted claim of the Patents-in-suit that Par contends is not infringed, describe External link to document
2014-05-30 37 , U.S. Patent No. 7,601,758 (the “’758 patent”), U.S. Patent No. 7,820,681 (the “’681 patent”), U.S. … of patent exclusivity on Colcrys®. These patents are U.S. Patent No. 7,619,004 (the “’004 patent”), …. Patent No.7,915,269 (the “’269 patent”), U.S. Patent No. 7,964,647 (the “’647 patent”); U.S. Patent…7,964,648 (the “’648 patent”), U.S. Patent No.7,981,938 (the “’938 patent”), U.S. Patent No.8,093,296 (the…the “’296 patent”), U.S. Patent No.8,093,297 (the “’297 patent”), U.S. Patent No. 8,097,655 (the “’655 External link to document
2013-10-21 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,906,519; US 7,935,731; US… 21 October 2013 1:13-cv-01729 830 Patent None District Court, D. Delaware External link to document
2014-09-04 67 G. United States Patent Number 7,601,758 (“the ‘758 Patent”), entitled “METHODS FOR CONCOMITANT…States Patent Nos. 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; 7,619,004; 7,601,758; 7,820,681… This is an action for patent infringement under the Food and Drug and Patent Laws of the United States… A. United Sates Patent Number 7,906,519 (“the ‘519 Patent”), entitled “METHODS FOR CONCOMITANT… B. United States Patent Number 7,935,731 (“the ‘731 Patent”), entitled “METHODS FOR CONCOMITANT External link to document
2014-09-09 68 ; 8,093,298; 8,093,297; 7,964,648; 7,619,004; 7,601,758; 7,820,681; 7,915,269; 7,964,647; 7,981,938; 8,093,296… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731… 21 October 2013 1:13-cv-01729 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
McKesson
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.